Search
New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
10 big data blunders to avoid
By
Companies make common data science mistakes. Here’s an expert’s guide to what they are and how to avoid them.
Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
MIT Sloan and King’s College London host summit on healthcare systems
By
“Building Sustainable Healthcare Systems through Innovation and Entrepreneurship” will bring together entrepreneurs, academics, healthcare professionals and policymakers from around the world.
Using data science to forecast clinical trial outcomes
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
Finance at MIT Ecosystem
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
MIT Sloan to host conference in London on accelerating growth in the developing world
By
Legatum Center event will focus on development, entrepreneurship and finance
MIT LFE and Informa Pharma Intelligence launch Project ALPHA
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
Robots could give humans ‘superpowers’
By
In a new book, MIT roboticist Daniela Rus looks at the powers and limitations of robots and how humans can work with them to unlock new capabilities.